Evaluating cancer risk in a large cohort of 25,008 patients with vitiligo: Insights from a comprehensive cohort population-based study
- 2 December 2024
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 92 (4) , 741-752
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Update on the pathogenesis of vitiligoAnais Brasileiros de Dermatologia, 2022
- Risk of skin cancer in patients with vitiligo in Denmark: A nationwide cohort studyJAAD International, 2020
- Inverse Relationship between Vitiligo-Related Genes and Skin Cancer RiskJournal of Investigative Dermatology, 2018
- Vitamin D and the Skin: An Update for DermatologistsAmerican Journal of Clinical Dermatology, 2017
- Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo PatientsDermatologic Clinics, 2017
- Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligoJournal of the American Academy of Dermatology, 2014
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgarisJournal of the American Academy of Dermatology, 2010
- Vitamin D and Autoimmune Rheumatologic DisordersAutoimmunity Reviews, 2010
- Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligoJournal of the American Academy of Dermatology, 2009